Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 6

1.

Laser therapy for onychomycosis in patients with diabetes at risk for foot ulcers: a randomized, quadruple-blind, sham-controlled trial (LASER-1).

Nijenhuis-Rosien L, Kleefstra N, van Dijk PR, Wolfhagen MJHM, Groenier KH, Bilo HJG, Landman GWD.

J Eur Acad Dermatol Venereol. 2019 Nov;33(11):2143-2150. doi: 10.1111/jdv.15601. Epub 2019 Jul 9.

PMID:
30920059
2.

Nationwide diabetes-related lower extremity amputation rates in secondary care treated patients with diabetes in the Netherlands (DUDE-7).

Nijenhuis-Rosien L, Hendriks SH, Kleefstra N, Bilo HJ, Landman GW.

J Diabetes Complications. 2017 Apr;31(4):675-678. doi: 10.1016/j.jdiacomp.2017.01.015. Epub 2017 Feb 2.

PMID:
28214067
3.
4.

Limited joint mobility syndrome in diabetes mellitus: A minireview.

Gerrits EG, Landman GW, Nijenhuis-Rosien L, Bilo HJ.

World J Diabetes. 2015 Aug 10;6(9):1108-12. doi: 10.4239/wjd.v6.i9.1108. Review.

5.

Laser therapy for onychomycosis in patients with diabetes at risk for foot complications: study protocol for a randomized, double-blind, controlled trial (LASER-1).

Nijenhuis-Rosien L, Kleefstra N, Wolfhagen MJ, Groenier KH, Bilo HJ, Landman GW.

Trials. 2015 Mar 22;16:108. doi: 10.1186/s13063-015-0622-4.

6.

Comment on Lazaro-Martinez et al. Antibiotics versus conservative surgery for treating diabetic foot osteomyelitis: a randomized comparative trial. Diabetes care 2014;37:789-795.

Landman GW, Nijenhuis-Rosien L, Kleefstra N.

Diabetes Care. 2014 May;37(5):e115. doi: 10.2337/dc13-2979. No abstract available.

PMID:
24757242

Supplemental Content

Loading ...
Support Center